Welcome to our dedicated page for Identa Rvice news (Ticker: IDTA), a resource for investors and traders seeking the latest updates and insights on Identa Rvice stock.
IDenta Corp. (IDTA) develops and supplies rapid field detection, home diagnostic testing, and forensic identification products for narcotics, drugs, explosives, homeland security, law enforcement, and consumer markets. Company news centers on periodic financial results, profitability, cash position, working capital, inventory, customer activity, and product delivery for government agencies, law enforcement organizations, distributors, and other global customers.
Recurring updates also cover market expansion, distributor relationships, operational efficiency, product development, and shareholder meeting or governance matters tied to the company's public-company structure.
IDenta Corp. (OTCQB: IDTA) reported a significant sales revenue increase of over 44% for Q2 2020, reaching $495,666 compared to $342,986 in Q2 2019. The gross profit also rose by 37% to $242,526, while operating profit more than doubled to $101,595. Net profit surged to $96,424, marking a 250% increase. Cash and equivalents increased dramatically to $639,705, fueled by customer prepayments and improved profitability. CEO Amichai Glattstein expressed optimism about the company's future, citing operational improvements and a strong sales pipeline.